What are the differences between humoral immunity and cell-dedicated immunity?
Posted November 7, 2023
Basis of differentiation |
Humoral immunity |
Cell-dedicated immunity |
Definition |
Is a form of immunity in which B-lymphocytes and plasma cells produce antibodies to defend against pathogens and foreign substances in the body |
Is a form of immunity in which specialized T cells direct target and destroy infected or abnormal cells in the body |
Components produced |
Produces components of B-cell and T-cell antibodies |
Produces components of helper T-cells, cytotoxic T- cells, natural killer (NK)-cells and macrophages |
Main cells involved in immunity | B-cells |
Mature T-cells and lymphocytes |
Protection against |
Extracellular bacterial or viral pathogens |
Viruses, fungi, and intracellular bacterial pathogens |
Pathogen recognition and response |
Recognizes and reacts to antigens or pathogens circulating in the lymph or blood |
Responds to all cells that exhibit anomalous MHC markers, including cells invaded by pathogens, tumor cells, or transplanted cells |
Immunological surveillance |
Does not provide immunological surveillance |
Provides immunological surveillance due to the presence of an MHC class of molecules |
Line of defense |
Is the first line of defense |
Is the second line of defense |
Activation |
Always active in the body and circulated by body fluid |
Only active when triggered by mature T-Cells and macrophages |
Type of T-cell involved |
Helper T-cell (CD4+) |
Helper T-cell (CD4+) and cytotoxic T-cell (CD8+) |
Receptor Involved |
B-cell receptors (BCRs) |
T-cell receptors (TCRs) |
Antigen detectors |
Phagocytes and antibodies themselves |
Receptors and MHC molecules present on the cell surfaces |
Antigen processing and presentation |
Not required |
Is required for T-lymphocyte mediated response |
Antigen Binding |
Antibodies, which are produced by B-cells, bind to antigens |
T-cells bind to T-cell receptors on cells before binding to antigens |
Antibodies formation |
Antibodies are formed |
Antibodies are not formed |
Onset |
Rapid onset |
Delayed onset |
Result |
Activation results in the differentiation of plasma B-cells and secreting antibodies |
Activation results in cytokine secretion |
Type of hypersensitivity reactions mediated |
Hypersensitivity type I, II, and III |
Hypersensitivity type IV |
Immunity against cancer |
Does not provide immunity against cancer |
Provides protection against cancer by destroying the tumor and cancerous cells |
Role in organ transplantation and grafting |
May be involved in early graft rejection because of preformed antibodies |
Is involved in rejections of organ transplants |
Assessment method |
From plasma level of antibodies |
Skin test for the development of delayed-type of hypersensitivity |